← Back to Patent Explorer
US4444760A Expired / Lapsed US ⏱️ 0.0 years remaining

Purification and characterization of a protein fibroblast growth factor

Assignee: Merck and Co Inc
•
Filing: 1983-06-17
•
Granted: 1984-04-24
•
Expires: 2003-06-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Acidic brain fibroblast growth factor isolated from bovine brain, is purified by a particular combination of protein purification techniques. The product is useful in the promotion of cell division (mitogenesis) such as in the promotion of wound healing.

Inventors

  • 👤 Kenneth A. Thomas, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 20:45
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/50; C07K14/501; A; A61; A61P; A61P43/00; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/839

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 70 words
An acidic brain fibroblast growth factor in substantially pure form with molecular mass of 16,600 or 16,800 daltons and an amino acid composition of: ______________________________________ Amino Acid Units ______________________________________ Aspartic Acid 14 Asparagine Threonine 9 Serine 10 Glutamic Acid 16 Glutamine Proline 7 Glycine 14 Alanine 5 Cysteine 4 Valine 5 Methionine 1 Isoleucine 6 Leucine 19 Tyrosine 7 Phenylalanine 7 Histidine 5 Lysine 13 Arginine 6 Tryptophan 1 ______________________________________
Claim 2
Dependent Claim 70 words
An acidic brain fibroblast growth factor in substantially pure form with molecular mass of 16,600 or 16,800 daltons and an amino acid composition of: ______________________________________ Amino Acid Units ______________________________________ Aspartic Acid 14 Asparagine Threonine 9 Serine 10 Glutamic Acid 16 Glutamine Proline 7 Glycine 14 Alanine 5 Cysteine 4 Valine 5 Methionine 1 Isoleucine 6 Leucine 19 Tyrosine 7 Phenylalanine 7 Histidine 5 Lysine 13 Arginine 6 Tryptophan 1 ______________________________________
Claim 3
Dependent Claim 13 words
The acidic brain fibroblast growth factor of claim 1, isolated from bovine brain.
Claim 4
Dependent Claim 49 words
A process for the isolation of acidic brain fibroblast growth factor in substantially pure form which comprises the sequence of steps of: (1) extraction and differential salt precipitation from the source tissue; (2) ion exchange; (3) gel filtration; (4) ion exchange; (5) isoelectric focusing; (6) hydrophobic reverse phase chromatography.
Claim 5
Dependent Claim 49 words
A process for the isolation of acidic brain fibroblast growth factor in substantially pure form which comprises the sequence of steps of: (1) extraction and differential salt precipitation from the source tissue; (2) ion exchange; (3) gel filtration; (4) ion exchange; (5) isoelectric focusing; (6) hydrophobic reverse phase chromatography.
Claim 6
Dependent Claim 11 words
The process of claim 3 for the isolation from bovine brain.
Claim 7
Dependent Claim 196 words
The process of claim 3 wherein: (1) The extraction and differential salt precipitation is accomplished by sequential treatments with 0.15 M ammonium sulfate at pH 4.5; 1.52 M ammonium sulfate at pH 6.75; and 3.41 M ammonium sulfate at pH 6.75 followed by dialysis and lyophilization of the high salt precipitate; (2) the ion exchange comprises batch adsorption on carboxymethyl-Sephadex (Pharmacia) resin at pH 6 followed by sequential elution with 0.1 M sodium phosphate buffer containing 0.15 M and 0.60 M sodium chloride followed by dialysis and lyophilization of the 0.60 M sodium chloride fraction, (3) gel filtration on a Sephadex G-75 (Pharmacia) column by elution with 0.1 M ammonium bicarbonate, pH 8.5 followed by lyophilization of the pooled high activity fractions; (4) ion exchange on a carboxymethyl cellulose column loaded in 0.1 M ammonium formate, pH 6.0 and eluted with 0.2 M and 0.6 M ammonium formate, pH 6.0, in sequence followed by lyophilization of the active pool; (5) isoelectric focusing is in Ultrodex (LKB, Gaithersburg, Md.); and (6) hydrophobic reverse phase high performance liquid chromatographic purification of the acidic mitogen is on Vydac C 4 silica based HPLC column (The Separations Group, Hesperia, Calif.).
Claim 8
Dependent Claim 11 words
The process of claim 5 for the isolation from bovine brain.
Claim 9
Dependent Claim 23 words
A pharmaceutical growth promoting composition comprising a pharmaceutical carrier and an effective growth promoting amount of the fibroblast growth factor of claim 1.
Claim 10
Dependent Claim 32 words
A method of promoting wound healing which comprises the administration to a patient in need of such treatment of an effective growth promoting amount of the fibroblast growth factor of claim 1.

References Cited (Backward Citations)

US4195017A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-04-24 1987-10-24 1988-04-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-04-24 1991-10-24 1992-04-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-04-24 1995-10-24 1996-04-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag